, Singapore
570 views
/Piasupuntongpool from Envato

Manulife unveils plans with up to 400% critical illness payouts

One of its plans covers 126 critical illnesses and conditions.

Manulife Singapore has introduced two new insurance options to address concerns over serious illnesses.

The Manulife Early CompleteCare (MECC) plan provides coverage for 126 critical illness conditions across all stages, whilst the Manulife EarlyCancer Protect (MECP) plan offers affordable term coverage for all stages of cancer. 

MECC offers a full payout of the sum insured upon diagnosis of any critical illness. 

It also includes features such as a Continuous Cancer Income option, which provides monthly payouts of 4% of the sum insured for up to 60 months, potentially reaching 240% of the insured amount. 

Additionally, its Cover Me Again benefit allows up to four extra critical illness claims, totalling 400% of the sum insured, whilst its Recurring Major Critical Illness benefit provides additional coverage for specific recurring conditions, up to 200% of the sum insured. 

The plan also guarantees a death benefit of at least eight times the annual premium. It covers all stages of cancer and offers a 100% payout upon diagnosis or death.
 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.